Skip to content

Study of signs, symptoms and associated diseases of adenoid hypertrophy in children aged 3 to 15 years

Study of Clinical features and comorbidities associated with adenoid hypertrophy in children aged 3 to 15 years - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/059094
Enrollment
500
Registered
2023-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Sponsors

Meenal Kalra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All children in the age group of 3 years to 15 years who were suspected of adenoid hypertrophy by pediatricians and underwent lateral neck X-rays at Kasturba Hospital, Manipal. 2. Children who were evaluated for the first time will only be included.

Exclusion criteria

Exclusion criteria: 1. Children whose parents deny consent for study. 2. Children with known congenital anomalies especially of upper respiratory tract. 3. Previously diagnosed AH and those undergoing treatment. 4. Repeat evaluation of adenoid with X-ray of the lateral neck in a child who is already enrolled. 5. Children with syndromic features. 6. Poor quality lateral neck X-rays. 7. Children with symptoms of AH but lateral neck X ray is not done.

Design outcomes

Primary

MeasureTime frame
Clinical features or presentation of adenoid hypertrophy in children aged 3 to 15 yearsTimepoint: Clinical features or presentation of adenoid hypertrophy in children aged 3 to 15 years

Secondary

MeasureTime frame
Comorbidities associated with adenoid hypertrophyTimepoint: At baseline/at presentation

Countries

India

Contacts

Public ContactDr Meenal Kalra

Kasturba Medical College

docrameshbhat@yahoo.co.in9686401313

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026